Contracepção – CEMICAMP

Manifestações clínicas de usuárias de contraceptivos com somente progestogênios

Alterações gênicas associadas ao sangramento vaginal de mulheres usuárias de sistema intrauterino de levonorgestrel e do implante subdérmico com etonogestrel

Uptake of highly effective contraception and prevention of unplanned pregnancy in adolescent girls by provision of the etonogestrel-releasing implant (Implanon NXT®) at the immediate postpartum period (IPP), compared with any method choices 6 weeks PP (standard of care (SOC)

MISP: "Real world evidence of the impact of access, increase knowledge and counseling about the etonogestrel-releasing implant (Implanon NXT®) and the effect upon pregnancy rate, reasons and rates for discontinuation and continuation rate up to two years after insertion in a Brazilian clinic when compared to short acting reversible contraceptives (SHARC)."

Avaliação de tratamento, características clínicas e endometriais de usuárias do implante contraceptivo liberador de etonogestrel com padrão de sangramento uterino desfavorável

A Study to Evaluate the Effectiveness, Pharmacokinetics, Safety, and Acceptability of Sayana® Press when Injected Every Four Months